Morning Briefing
Summaries of health policy coverage from major news organizations
GSK To Offer Scientists Access To Compounds, Lab Space To Fight Malaria
Drugmaker GlaxoSmithKline (GSK)'s chief executive officer Andrew Witty on Tuesday unveiled the company's plans to allow "free access to its library of 13,500 potential malaria treatments and devote the profits from its experimental [RTS,S] vaccine to battling tropical illnesses that beset poor countries," Bloomberg reports (Randall, 1/20).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
